Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease
Luca Miele, Maria Assunta Zocco, Fabrizio Pizzolante, et al.
Metabolism (2020) Vol. 112, pp. 154355-154355
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Butyrate to combat obesity and obesity‐associated metabolic disorders: Current status and future implications for therapeutic use
Thirza van Deuren, Ellen E. Blaak, Emanuel E. Canfora
Obesity Reviews (2022) Vol. 23, Iss. 10
Open Access | Times Cited: 81
Non-invasive testing and risk-stratification in patients with MASLD
Mirko Zoncapè, Antonio Liguori, Emmanuel Tsochatzis
European Journal of Internal Medicine (2024) Vol. 122, pp. 11-19
Closed Access | Times Cited: 36
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals
Chiara Saponaro, Silvia Sabatini, Melania Gaggini, et al.
Liver International (2022) Vol. 42, Iss. 11, pp. 2418-2427
Open Access | Times Cited: 59
The steatosis‐associated fibrosis estimator (SAFE) score: A tool to detect low‐risk NAFLD in primary care
Pimsiri Sripongpun, W. Ray Kim, Ajitha Mannalithara, et al.
Hepatology (2022) Vol. 77, Iss. 1, pp. 256-267
Open Access | Times Cited: 49
Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus
Julia Blomdahl, Patrik Nasr, Mattias Ekstedt, et al.
Metabolism (2020) Vol. 115, pp. 154439-154439
Open Access | Times Cited: 63
Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
Laura Valenzuela‐Vallejo, Despina Sanoudou, Christos S. Mantzoros
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 830-830
Open Access | Times Cited: 18
Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study
Vy H. Nguyen, Isaac Le, Audrey Ha, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 4, pp. 1002-1012
Open Access | Times Cited: 16
A superoxide anion activatable near-infrared fluorescent probe with a large Stokes shift for imaging of drug-induced liver injury
Qian-Qian Wang, Shi-Peng Wu, Jin-He Yang, et al.
Microchemical Journal (2024) Vol. 200, pp. 110288-110288
Closed Access | Times Cited: 6
Hepatic Steatosis Index and the Risk of Type 2 Diabetes Mellitus in China: Insights from a General Population-Based Cohort Study
Xintian Cai, Jing Gao, Shasha Liu, et al.
Disease Markers (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 16
Omics-based biomarkers as useful tools in metabolic dysfunction-associated steatotic liver disease clinical practice: How far are we?
Julieta Trinks, María Florencia Mascardi, Adrián Gadano, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 14, pp. 1982-1989
Open Access | Times Cited: 3
The Liver in Heart Failure: From Biomarkers to Clinical Risk
Nadia Aspromonte, Isabella Fumarulo, Lucrezia Petrucci, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15665-15665
Open Access | Times Cited: 8
FibroScan’s evolution: a critical 20-year review
Nisar Ahmed, Ayushi Kumari, R. Srinivasa Murty
Journal of Ultrasound (2024)
Closed Access | Times Cited: 2
Liver fat analysis using optimized support vector machine with support vector regression
B. Pushpa, B. Baskaran, S. Vivekanandan, et al.
Technology and Health Care (2023) Vol. 31, Iss. 3, pp. 867-886
Closed Access | Times Cited: 6
The role of elastography in non-alcoholic fatty liver disease
Antonio Liguori, Maria Elena Ainora, Laura Riccardi, et al.
Minerva Gastroenterology (2021) Vol. 67, Iss. 2
Closed Access | Times Cited: 14
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study
Zhongwei Chen, Huanming Xiao, Xinjian Ye, et al.
HepatoBiliary Surgery and Nutrition (2021) Vol. 11, Iss. 2, pp. 212-226
Open Access | Times Cited: 11
Development and validation of a novel non-invasive test for diagnosing nonalcoholic fatty liver disease in Chinese children
Zhe-Wen Qin, Qiannan Ren, Hongxi Zhang, et al.
World Journal of Pediatrics (2023) Vol. 20, Iss. 4, pp. 413-421
Closed Access | Times Cited: 3
Adipose tissue dysfunction and visceral fat are associated to hepatic insulin resistance and severity of NASH even in lean individuals
Chiara Saponaro, Silvia Sabatini, Melania Gaggini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Circulating irisin in nonalcoholic fatty liver disease: an updated meta-analysis
Shanhu Qiu, Qianqian Wang, Xue Cai, et al.
Endokrynologia Polska (2022) Vol. 74, Iss. 1, pp. 47-54
Open Access | Times Cited: 4
Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT
Jeong Ah Hwang, Ji Hye Min, Tae Wook Kang, et al.
European Radiology (2021) Vol. 31, Iss. 10, pp. 7760-7770
Closed Access | Times Cited: 5
Long-term statin treatment for hepatic fibrosis in patients with nonalcoholic fatty liver disease: Is it time to give the emperor a statin robe?
Christopher M. Tessier, Stergios A. Pοlyzos, Vasilios G. Athyros, et al.
Metabolism (2021) Vol. 121, pp. 154796-154796
Closed Access | Times Cited: 5
Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease
Antonio Liguori, Mirko Zoncapè, Emmanuel Tsochatzis
Revista Española de Enfermedades Digestivas (2022)
Open Access | Times Cited: 3
Irisin in nonalcoholic fatty liver disease: need for an updated meta-analysis
Stergios A. Pοlyzos, Jannis Kountouras, Athanasios D. Anastasilakis
Metabolism (2021) Vol. 121, pp. 154818-154818
Closed Access | Times Cited: 4
Associations Between Multiparametric US-Based Indicators and Pathological Status in Patients with Metabolic Associated Fatty Liver Disease
Yan Zhou, Mengjin Nie, Feng Mao, et al.
Ultrasound in Medicine & Biology (2024) Vol. 50, Iss. 9, pp. 1395-1402
Closed Access
Reliability and stability of ultrasound-guided attenuation parameter in evaluating hepatic steatosis
Xiaodan Zhang, Liping Luo, Huahui Liu, et al.
Journal of Ultrasound (2024) Vol. 27, Iss. 1, pp. 145-152
Closed Access
Extracellular Vesicles as Biomarkers for Steatosis Stages in MASLD Patients: an Algorithmic Approach Using Explainable Artificial Intelligence
Eleni-Myrto Trifylli, Athanasios Angelakis, Anastasios G. Kriebardis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top